SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-095448
Filing Date
2020-08-14
Accepted
2020-08-14 15:17:12
Documents
1
Period of Report
2020-08-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2027709d4_4.html 4  
1 OWNERSHIP DOCUMENT tm2027709d4_4.xml 4 4075
  Complete submission text file 0001104659-20-095448.txt   5741
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IMMUNOMEDICS, INC. 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address
Islam Khalid (Reporting) CIK: 0001701858 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 201104428